Healthleap has raised $38 million to expand software that scans hospital records for signs of conditions that may have gone unnoticed. The platform highlights patients for additional review, while leaving diagnosis and care decisions to clinicians.
Turning chart details into review prompts
Hospital records contain both structured data, such as lab results and vital signs, and written notes from clinicians. Healthleap uses language models to look through those notes for mentions of clinical concepts, including recent weight loss, poor appetite, muscle loss, or difficulty swallowing. Its risk models combine those findings with structured information.
The company says it analyzes every adult inpatient’s record each night, including medications, diet orders, diagnoses, weights, and clinicians’ notes. Each morning, it writes a risk score into the care team’s existing workflow. A dashboard provides more information about patients’ trends.
The software does not diagnose anyone. It is intended to help care teams identify records that may deserve a closer look, including cases where relevant signs appear across different parts of a chart.
Starting with conditions that can be missed
Healthleap began with malnutrition, a condition the source describes as often going undiagnosed and capable of affecting recovery. Research cited in the source suggests 20% to 50% of hospital inpatients are malnourished. Some studies have linked malnutrition to longer stays, impaired wound healing, infections, other complications, and higher morbidity and mortality.
The platform is deployed in more than 50 hospitals, screening for malnutrition and delirium. Healthleap has also developed programs to identify aspiration pneumonia, pressure ulcers, and risk of readmission for congestive heart failure. Those programs are undergoing further clinical validation.
This approach depends on making information in written notes usable alongside the structured data hospitals already collect. A mention of a symptom or change in condition can contribute to a risk signal, but the result is a prompt for review rather than a clinical conclusion.
Funding follows hospital expansion
The financing includes an $8 million seed round co-led by Sequoia Capital and First Round Capital, followed by a $30 million Series A led by Hummingbird Ventures. Healthleap is not disclosing its valuation.
Siblings Jemima and Josiah Meyer founded the company in South Africa in 2022. It first offered a clinical nutrition tool Jemima had built for dietitians, then shifted toward a broader platform for identifying hospital patients who might have undiagnosed conditions. Josiah Meyer is the CEO and co-founder.
Josiah said Healthleap grew from three hospital partners to more than 50 over the past year, and that revenue grew more than 10x over the same period. Customers now include Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare.
Measuring value and broadening the platform
Healthleap sells three-year contracts priced according to a hospital’s licensed bed count and also uses outcome-based pricing. Josiah said the company uses financial returns validated and attributed by hospital finance teams. He said every customer to date has seen a 5x hard ROI or more, with some seeing over 20x annual total ROI.
At the Hospital of the University of Pennsylvania, Healthleap says its malnutrition program produced $23.8 million in annualized financial impact. The company attributes $6.3 million to additional reimbursement and $17.5 million to shorter hospital stays.
The new funding will support engineering, product, sales, and customer success as Healthleap adds support for more conditions. Josiah said the company ultimately wants to cover more than 40 major health conditions and expand into outpatient and home care.